• No results found

Economic support to improve tuberculosis treatment outcomes in South Africa: a pragmatic cluster randomized controlled trial

N/A
N/A
Protected

Academic year: 2020

Share "Economic support to improve tuberculosis treatment outcomes in South Africa: a pragmatic cluster randomized controlled trial"

Copied!
13
0
0

Loading.... (view fulltext now)

Full text

Loading

Figure

Figure 1 Participant flow diagram.
Table 1 Prices of selected food stuffs commonly used inSouth African households, January 2010 (mid-waythrough trial) [37]
Table 2 Baseline characteristics of trial cohorts
Table 3 Primary outcome (treatment success) - intention to treat and exploratory analyses
+3

References

Related documents

Conclusion: This study highlights the lack of understanding and confusion regarding issues surrounding brain death in this region especially among junior doctors and highlights

Orofacial treatment in addition to usual manual therapy care focussed on the cervical spine was more effective than usual care alone, in improving cervical movement impairment in

Some drugs exhibit a significantly increased (up to three-fold) mean oral bioavailability when co-administered with grapefruit juice. Bailey et al [125] reported that the

If this holds true for bilateral agreements with rules on fossil fuels imports and exports, it appears less evident in respect of the rules on renewable energy generation (due

Envirco’s ENV1028 Universal Control Card provides MODBUS network and analog control capabilities to an Envirco Fan Filter Unit equipped with an electrically commutated motor..

We describe three methods of generating high bandwidth network traces: scaling low bandwidth network traffic traces, merging multiple low bandwidth traces and generating traces

sSIRS, severe systematic inflammatory response syndrome; ICU, intensive care unit; TAR, total arch replacement.. ICU, intensive care unit; TAR, total arch replacement; sSIRS,

In cutaneous melanoma, combined check- point blockade with ipilimumab and nivolumab revealed response rates and survival outcomes superior to PD-1 inhibitor monotherapy, albeit at